Wednesday, February 10, 2010, 12:58PM AEST - The Australian Stockmarket closes in 3 hours and 7 minutes.
To create a watchlist or portfolio of shares, Register

Gen-Probe Inc. (GPRO)

8:00AM AEST: 43.19 USD  Up 0.35 (0.82%)  
 MORE ON GPRO 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Gen-Probe Incorporated (NasdaqNM:GPRO) Delayed quote dataEdit
Last Trade:43.19 USD
Trade Time: 8:00AM AEST
Change:Up 0.35 (0.82%)
Prev Close:42.84
Open:42.98
Bid:40.94 x 100
Ask:N/A
1y Target Est:49.23
Day's Range:42.67 - 43.50
52wk Range:35.70 - 49.29
Volume:246,159
Avg Vol (3m):313,781
Market Cap:2.12B
P/E (ttm):25.32
EPS (ttm):1.71
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add GPRO to Portfolio   Download Data

 HEADLINES 
Molecular Diagnostics Industry Creates New Sector With High Growth And Rapid Valuation Formation Characteristics For Investors According To Industry Expert
Wall Street Transcript (Thu, Jan 28)
An In-Depth Look At Diagnostics Companies And Stock Evaluations From Dr. Ashim Anand Of Natixis Bleichroeder, LLC
Wall Street Transcript (Tue, Jan 26)
Coverage initiated on Gen-Probe by Jefferies & Co
Briefing.com (Thu, Jan 21)
Gen-Probe Earnings Call scheduled for Thu, Feb 18
CCBN (Fri, Jan 15)
Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2009 Earnings Conference Call
Business Wire (Fri, Jan 15)
Gen-Probe to Webcast Presentation at the 28th Annual J.P. Morgan Healthcare Conference
PR Newswire (Wed, Jan 6)
Neogen Beats by a Penny
Zacks.com (Wed, Dec 23)
Neogen 2Q profit rises on food safety sales
AP (Sat, Dec 19)
4-Star Stocks on the Upswing
at Motley Fool (Thu, Dec 17)
GEN PROBE INC Files SEC form 8-K, Other Events
EDGAR Online (Wed, Dec 16)
Technical Setups: Frontline, Gen-Probe
at TheStreet.com (Wed, Dec 16)
More Headlines for GPRO...

 ANALYST 
EPS Est (next year) (Dec-09) :1.92
EPS Est (in 2 years) (Dec-10) :2.17
Avg Rec (current)*:2.1
PEG Ratio:1.71
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Gen-Probe Incorporated develops, manufactures, and markets nucleic acid probe-based products used for the clinical diagnosis of human diseases, and for screening donated human blood in North America and internationally.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices